With the enactment of the PACT Act, veterans are now eligible to presumptively service connect hypertension and monoclonal gammopathy – which are medical conditions related to Agent Orange exposure. This change will provide millions of veterans with an easier pathway to establish monthly VA disability compensation for disabilities related to their military service.
Monoclonal Gammopathy is a condition in which abnormal proteins are found in the blood. The most common condition linked with these abnormal proteins is monoclonal gammopathy of undetermined significance (MGUS), which involves a greater risk of serious diseases of the bone marrow and blood.
Current research has determined that the progression of MGUS can lead to light chain amyloidosis, chronic B-cell leukemia, and multiple myeloma – which are conditions with well-established links to Agent Orange exposure. With the PACT Act, veterans can now easily service-connect their MGUS claims.
Hypertension, also known as high blood pressure, is a condition involving abnormal blood circulation, putting strain against the artery walls. An individual can live with hypertension without any symptoms. However, untreated hypertension can cause severe health complications, such as heart problems that can eventually lead to heart attack, aneurysms, stroke, and heart failure. With the PACT Act, VA now recognizes the connection between Agent Orange exposure and hypertension in affected veterans.
The changes created by the PACT Act are a step closer to providing increased access to the benefits and healthcare for veterans. Rob Levine & Associates is committed to using every advantage in the law, including the changes implemented by the PACT Act, to help veterans get the benefits they deserve. If you are a veteran impacted by military toxic exposures, please contact us today to receive a free case evaluation by our VA Disability Team!